11. Clinical trials: how to cope with medical needs, ethics and timelines. Issue 01 (9th December 2009) Authors: Rubbert-Roth, Andrea; Burmester, Gerd-Rüdiger Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 01(2010) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis. Issue 7 (14th July 2021) Authors: Gilbert, Benoit Thomas P; Lamacchia, Céline; Mongin, Denis; Lauper, Kim; Trunk, Eric; Studer, Olivia; Courvoisier, Delphine S; Rubbert-Roth, Andrea; Kyburz, Diego; Moeller, Burkhard; Finckh, Axel Journal: BMJ open Issue: Volume 11:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Combination therapies in rheumatoid arthritis—choose your partner carefully. (June 2022) Authors: Rubbert-Roth, Andrea Journal: Lancet Issue: Volume 4:Number 6(2022) Page Start: e376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. (17th May 2022) Authors: Amstad, Andrea; Papagiannoulis, Eleftherios; Scherer, Almut; Rubbert-Roth, Andrea; Finckh, Axel; Mueller, Ruediger; Dudler, Jean; Möller, Burkhard; Villiger, Peter M; Schulz, Martin M P; Kyburz, Diego Journal: Rheumatology Issue: Volume 62:Number 1(2023) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions. Issue 4 (21st November 2012) Authors: Smolen, Josef S; Schoels, Monika M; Nishimoto, Norihiro; Breedveld, Ferdinand C; Burmester, Gerd R; Dougados, Maxime; Emery, Paul; Ferraccioli, Gianfranco; Gabay, Cem; Gibofsky, Allan; Gomez-Reino, Juan Jesus; Jones, Graeme; Kvien, Tore K; Murakami, Miho; Betteridge, Neil; Bingham, Clifton O; Byk... Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 4(2013) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis. (26th August 2020) Authors: Rubbert-Roth, Andrea; Aletaha, Daniel; Devenport, Jenny; Sidiropoulos, Paris N; Luder, Yves; Edwardes, Michael D; Jacobs, Johannes W G Journal: Rheumatology Issue: Volume 60:Number 2(2021) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials. (18th December 2016) Authors: Moots, Robert J.; Sebba, Anthony; Rigby, William; Ostor, Andrew; Porter-Brown, Benjamin; Donaldson, Francis; Dimonaco, Sophie; Rubbert-Roth, Andrea; van Vollenhoven, Ronald; Genovese, Mark C. Journal: Rheumatology Issue: Volume 56:Number 4(2017) Page Start: 541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). Issue 1 (8th June 2015) Authors: Burmester, Gerd R; Rubbert-Roth, Andrea; Cantagrel, Alain; Hall, Stephen; Leszczynski, Piotr; Feldman, Daniel; Rangaraj, Madura J; Roane, Georgia; Ludivico, Charles; Bao, Min; Rowell, Lucy; Davies, Claire; Mysler, Eduardo F Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 1(2016) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses. (January 2022) Authors: Schmiedeberg, Kristin; Vuilleumier, Nicolas; Pagano, Sabrina; Albrich, Werner C; Ludewig, Burkhard; Kempis, Johannes von; Rubbert-Roth, Andrea Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Issue 3 (25th October 2013) Authors: Smolen, Josef S; Landewé, Robert; Breedveld, Ferdinand C; Buch, Maya; Burmester, Gerd; Dougados, Maxime; Emery, Paul; Gaujoux-Viala, Cécile; Gossec, Laure; Nam, Jackie; Ramiro, Sofia; Winthrop, Kevin; de Wit, Maarten; Aletaha, Daniel; Betteridge, Neil; Bijlsma, Johannes W J; Boers, Maarten; Buttg... Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 3(2014) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗